Cargando…

Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be evaluated against L. infantum infection. Also, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Vivian Tamietti, Chávez-Fumagalli, Miguel Angel, Lage, Daniela Pagliara, Duarte, Mariana Costa, Garde, Esther, Costa, Lourena Emanuele, da Silva, Viviane Gomes, Oliveira, Jamil Silvano, de Magalhães-Soares, Danielle Ferreira, Teixeira, Santuza Maria Ribeiro, Fernandes, Ana Paula, Soto, Manuel, Tavares, Carlos Alberto Pereira, Coelho, Eduardo Antonio Ferraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569552/
https://www.ncbi.nlm.nih.gov/pubmed/26367128
http://dx.doi.org/10.1371/journal.pone.0137683
_version_ 1782390058175692800
author Martins, Vivian Tamietti
Chávez-Fumagalli, Miguel Angel
Lage, Daniela Pagliara
Duarte, Mariana Costa
Garde, Esther
Costa, Lourena Emanuele
da Silva, Viviane Gomes
Oliveira, Jamil Silvano
de Magalhães-Soares, Danielle Ferreira
Teixeira, Santuza Maria Ribeiro
Fernandes, Ana Paula
Soto, Manuel
Tavares, Carlos Alberto Pereira
Coelho, Eduardo Antonio Ferraz
author_facet Martins, Vivian Tamietti
Chávez-Fumagalli, Miguel Angel
Lage, Daniela Pagliara
Duarte, Mariana Costa
Garde, Esther
Costa, Lourena Emanuele
da Silva, Viviane Gomes
Oliveira, Jamil Silvano
de Magalhães-Soares, Danielle Ferreira
Teixeira, Santuza Maria Ribeiro
Fernandes, Ana Paula
Soto, Manuel
Tavares, Carlos Alberto Pereira
Coelho, Eduardo Antonio Ferraz
author_sort Martins, Vivian Tamietti
collection PubMed
description In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be evaluated against L. infantum infection. Also, the antigenicity of the three proteins was analyzed, and their use for the serodiagnosis of canine visceral leishmaniasis (CVL) was evaluated. The LiHyp1, LiHyp6, and HRF DNA coding sequences were cloned in prokaryotic expression vectors and the recombinant proteins were purified. When employed in ELISA assays, all proteins were recognized by sera from visceral leishmaniasis (VL) dogs, and presented no cross-reactivity with either sera from dogs vaccinated with a Brazilian commercial vaccine, or sera of Trypanosoma cruzi-infected or Ehrlichia canis-infected animals. In addition, the antigens were not recognized by antibodies from non-infected animals living in endemic or non-endemic areas for leishmaniasis. The immunogenicity and protective efficacy of the three proteins administered in the presence of saponin, individually or in combination (composing a polyproteins vaccine), were evaluated in a VL murine model: BALB/c mice infected with L. infantum. Spleen cells from mice inoculated with the individual proteins or with the polyproteins vaccine plus saponin showed a protein-specific production of IFN-γ, IL-12, and GM-CSF after an in vitro stimulation, which was maintained after infection. These animals presented significant reductions in the parasite burden in different evaluated organs, when compared to mice inoculated with saline or saponin. The decrease in parasite burden was associated with an IL-12-dependent production of IFN-γ against parasite total extracts (produced mainly by CD4(+) T cells), correlated to the induction of parasite proteins-driven NO production. Mice inoculated with the recombinant protein-based vaccines showed also high levels of parasite-specific IgG2a antibodies. The polyproteins vaccine administration induced a more pronounced Th1 response before and after challenge infection than individual vaccines, which was correlated to a higher control of parasite dissemination to internal organs.
format Online
Article
Text
id pubmed-4569552
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45695522015-09-18 Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis Martins, Vivian Tamietti Chávez-Fumagalli, Miguel Angel Lage, Daniela Pagliara Duarte, Mariana Costa Garde, Esther Costa, Lourena Emanuele da Silva, Viviane Gomes Oliveira, Jamil Silvano de Magalhães-Soares, Danielle Ferreira Teixeira, Santuza Maria Ribeiro Fernandes, Ana Paula Soto, Manuel Tavares, Carlos Alberto Pereira Coelho, Eduardo Antonio Ferraz PLoS One Research Article In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be evaluated against L. infantum infection. Also, the antigenicity of the three proteins was analyzed, and their use for the serodiagnosis of canine visceral leishmaniasis (CVL) was evaluated. The LiHyp1, LiHyp6, and HRF DNA coding sequences were cloned in prokaryotic expression vectors and the recombinant proteins were purified. When employed in ELISA assays, all proteins were recognized by sera from visceral leishmaniasis (VL) dogs, and presented no cross-reactivity with either sera from dogs vaccinated with a Brazilian commercial vaccine, or sera of Trypanosoma cruzi-infected or Ehrlichia canis-infected animals. In addition, the antigens were not recognized by antibodies from non-infected animals living in endemic or non-endemic areas for leishmaniasis. The immunogenicity and protective efficacy of the three proteins administered in the presence of saponin, individually or in combination (composing a polyproteins vaccine), were evaluated in a VL murine model: BALB/c mice infected with L. infantum. Spleen cells from mice inoculated with the individual proteins or with the polyproteins vaccine plus saponin showed a protein-specific production of IFN-γ, IL-12, and GM-CSF after an in vitro stimulation, which was maintained after infection. These animals presented significant reductions in the parasite burden in different evaluated organs, when compared to mice inoculated with saline or saponin. The decrease in parasite burden was associated with an IL-12-dependent production of IFN-γ against parasite total extracts (produced mainly by CD4(+) T cells), correlated to the induction of parasite proteins-driven NO production. Mice inoculated with the recombinant protein-based vaccines showed also high levels of parasite-specific IgG2a antibodies. The polyproteins vaccine administration induced a more pronounced Th1 response before and after challenge infection than individual vaccines, which was correlated to a higher control of parasite dissemination to internal organs. Public Library of Science 2015-09-14 /pmc/articles/PMC4569552/ /pubmed/26367128 http://dx.doi.org/10.1371/journal.pone.0137683 Text en © 2015 Martins et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Martins, Vivian Tamietti
Chávez-Fumagalli, Miguel Angel
Lage, Daniela Pagliara
Duarte, Mariana Costa
Garde, Esther
Costa, Lourena Emanuele
da Silva, Viviane Gomes
Oliveira, Jamil Silvano
de Magalhães-Soares, Danielle Ferreira
Teixeira, Santuza Maria Ribeiro
Fernandes, Ana Paula
Soto, Manuel
Tavares, Carlos Alberto Pereira
Coelho, Eduardo Antonio Ferraz
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title_full Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title_fullStr Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title_full_unstemmed Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title_short Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
title_sort antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of leishmania infantum against visceral leishmaniasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569552/
https://www.ncbi.nlm.nih.gov/pubmed/26367128
http://dx.doi.org/10.1371/journal.pone.0137683
work_keys_str_mv AT martinsviviantamietti antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT chavezfumagallimiguelangel antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT lagedanielapagliara antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT duartemarianacosta antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT gardeesther antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT costalourenaemanuele antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT dasilvavivianegomes antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT oliveirajamilsilvano antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT demagalhaessoaresdanielleferreira antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT teixeirasantuzamariaribeiro antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT fernandesanapaula antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT sotomanuel antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT tavarescarlosalbertopereira antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis
AT coelhoeduardoantonioferraz antigenicityimmunogenicityandprotectiveefficacyofthreeproteinsexpressedinthepromastigoteandamastigotestagesofleishmaniainfantumagainstvisceralleishmaniasis